Navigation Links
Europe Hemostasis Testing Market Reviewed in Insightful VPG Report Now Available at MarketPublishers.com
Date:8/14/2013

London, UK (PRWEB) August 14, 2013

Hemostasis testing practice is poised to witness considerable changes in the upcoming years. The factors influencing this change include the increasing cost containment pressures in the developed countries along with the ongoing technological advancements in molecular diagnostics, chromagenic substrates, immunoassays, monoclonal antibodies, computer and laboratory automation.

The demand for novel specific and sensitive hemostasis markers on automated instrumentation is expected to increase substantially in the offing. Hemostasis testing is also predicted to become more standardised, thus, bringing new opportunities for quality control services and products.

Insightful research report “Hemostasis Testing: Granular Analysis of European Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Spain, UK” worked out by Venture Planning Group (VPG) has been recently published by Market Publishers Ltd.

Report Details:

Title: Hemostasis Testing: Granular Analysis of European Market Supplier Shares and Forecasts for 40 Tests France, Germany, Italy, Spain, UK
Published: July, 2013
Price:    US$ 12,800.00
http://marketpublishers.com/report/life_sciences/diagnostics-diseases/hemostasis-testing-granular-analysis-of-european-market-supplier-shares-n-forecasts-4-40-tests-france-germany-italy-spain-uk.html

The report provides a comprehensive overview of the hemostasis testing markets in France, Germany, Italy, Spain and the UK. The study uncovers essential information on the industry performance, identifies and evaluates major market opportunities, presents an insightful market segmentation analysis. The report delves into the competitive landscape, offers vital details on the leading companies and contains data on the sales and shares of the major hemostasis testing instrument and reagent suppliers. In addition, the report discloses test forecasts for the 40 major procedures by market segment and by country.

Market segments covered in the study include: hospitals, commercial/private laboratories, physician offices and ambulatory care centers.

Reasons to Buy:

  •     The report offers an insightful analysis of the five country hemostasis testing markets in Europe (France, Germany, Italy, Spain and the UK).
  •     Vital data on the industry performance helps to get a comprehensive understanding of the current market situation.
  •     The research study allows current market players and potential market entrants to identify and evaluate the emerging market opportunities and turn them into the maximum benefit.
  •     Future forecast is essential for the planning of the effective business, marketing and new product development strategies.
  •     Details on the competitive landscape and the leading companies assist in gaining a competitive advantage in the market and in choosing the potential business partners.
More in-demand research reports by the publisher can be found at VPG page.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11026782.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
3. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
4. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
5. European Multiple Sclerosis Market in Dire Need of Increased Disease Awareness and Treatment Options, Cautions Frost & Sullivan
6. Islet Sciences Announces DiaKine Therapeutics Novel Diabetes, Atherosclerosis Drugs Receives European Patent Protection
7. Chronic Hepatic Diseases Generate High Costs to Europe
8. Tackling the European market of nanoimprint lithography
9. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
10. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
11. Global Markets for Enzymes in Industrial Applications -- Focus on Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , March 22, 2017   iSpecimen ®, ... announced that Doctors Pathology Service (DPS), a ... of the United States , has ... Delaware Health Information Network (DHIN) to make human ... The novel program, announced in 2015 as ...
(Date:3/22/2017)... March 22, 2017   VWR ... of product and service solutions to laboratory ... has acquired EPL Archives, Inc., an international ... the entire regulated product research, development and ... storage and ancillary services. EPL Archives is ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... more than tripling its goal and raising over $30,000 in the first 40 ... grows nutritious veggies & herbs fast, easy, and affordably, anywhere. , “Simply add ...
(Date:3/22/2017)... Iowa (PRWEB) , ... March 22, 2017 , ... March ... is time for another green revolution, one that utilizes technological innovation in smart, sustainable ... tangible aspects of life such as aesthetics and environmental stability. This paper is the ...
Breaking Biology Technology:
(Date:3/7/2017)... , March 7, 2017   HireVue , the ... global companies identify the best talent, faster, today announced ... Sales Officer (CSO) and Diana Kucer as ... out a seasoned executive team poised to drive continued growth ... on a year of record bookings in 2017. ...
(Date:3/2/2017)... 2, 2017 Australian stem cell and regenerative ... has signed an agreement with the Monash Lung Biology ... Discovery Institute and Department of Pharmacology at Monash University, ... preclinical study to support the use of Cymerus™ mesenchymal ... Asthma is a chronic, long term lung ...
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber Ventures ... it has led a $3.5 million investment in  Polarity ... Strategic Cyber Ventures is DC based and is led ... Hank Thomas . Ron Gula , also a ... also participated in this series A round of funding. ...
Breaking Biology News(10 mins):